Antiscience, Vaccine Hesitancy, and Pandemic Responses: Highlights from the Asia Pacific Summit on Infectious Diseases and Immunization.

Antiscience, Vaccine Hesitancy, and Pandemic Responses: Highlights from the Asia Pacific Summit on Infectious Diseases and Immunization.

Publication date: Nov 27, 2024

The recent resurgence of mpox highlights the urgent need for rethinking vaccination strategies globally, underscored by the painful memories of past public health crises where delayed responses and inequitable vaccine distribution exacerbated the spread of infectious diseases. The inaugural APIC-ADVA Asia Pacific Summit on Infectious Diseases and Immunization, themed “Vaccination for All: Access, Confidence and Equity (ACE)”, was held in Singapore from 31 October to 1 November 2023 in an attempt to present best practices and hard-won insights from battling COVID-19 and other pandemics in the Asia-Pacific region. This summit was co-convened by the Asia-Pacific Immunization Coalition (APIC) and Asia Dengue Voice and Action (ADVA). Local, regional, and international experts from academia, research and representatives from the Ministries of Health, the World Health Organization (WHO), and the International Vaccine Institute (IVI) participated in the 2 day summit. With more than 230 speakers and delegates from over 15 countries, and 4 symposia over 2 full days, the first APIC-ADVA Asia Pacific Summit on Infectious Diseases and Immunization highlighted critical issues affecting vaccine access, confidence, and equity, and emphasized the importance of safeguarding the world from existing infections and future pandemics through immunization.

Open Access PDF

Concepts Keywords
Academia antiscience
Asia antivaccine activism
October immunization
Painful immunization programs
Vaccine infectious diseases
pandemic response
public health
vaccine access
vaccine efficacy
vaccine hesitancy
vaccines

Semantics

Type Source Name
disease MESH Infectious Diseases
disease MESH COVID-19
disease MESH Dengue
disease MESH infections
disease IDO process
drug DRUGBANK Deoxy-2-Fluoro-B-D-Cellotrioside
drug DRUGBANK BIA
drug DRUGBANK Methyl isocyanate
disease IDO bacteria
drug DRUGBANK ATP
drug DRUGBANK Xylose
disease IDO protein
disease IDO assay
drug DRUGBANK Potassium Chloride
drug DRUGBANK Phosphate ion
pathway REACTOME Release
drug DRUGBANK Dextrose unspecified form
disease MESH L tryptophan
drug DRUGBANK Spectinomycin
drug DRUGBANK Erythromycin
drug DRUGBANK Lincomycin
drug DRUGBANK Kanamycin
drug DRUGBANK Ampicillin
disease IDO site
disease IDO object
drug DRUGBANK Tromethamine
drug DRUGBANK Edetic Acid
drug DRUGBANK Glycerin
drug DRUGBANK Omega-3 fatty acids
disease IDO cell

Original Article

(Visited 1 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *